학술논문

One-Year Treatment Outcomes of Secukinumab Versus Tumor Necrosis Factor Inhibitors in Spondyloarthritis: Results From Five Nordic Biologic Registries Including More Than 10,000 Treatment Courses
Document Type
Artikel
Source
Arthritis care & research. 74(5):748-758
Subject
Medicin och hälsovetenskap
Language
English
English
ISSN
2151-4658